|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-06
|
$394,250
|
PFEIFER, GERD
|
VAN ANDEL RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA015704-42S1
|
$249,999
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S2
|
$125,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S3
|
$58,085
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S4
|
$70,220
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA062203-20
|
$2,317,496
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Cancer Center Support Grant
|
3P30CA042014-28S1
|
$249,799
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S2
|
$123,315
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S3
|
$46,117
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S4
|
$59,999
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S5
|
$113,563
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S6
|
$75,709
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S7
|
$75,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S8
|
$166,146
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-28
|
$2,284,983
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA091842-16S1
|
$122,824
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-16S2
|
$243,947
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-16
|
$4,305,712
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Characterization of CD99 as a Therapeutic Target in the Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
1K08CA194275-01A1
|
$177,336
|
CHUNG, STEPHEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Characterizing the landscape of resistance and persistence mechanisms in CML
|
2R01CA065823-21A1
|
$329,175
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
CLONAL EVOLUTION OF HEMATOPOIETIC STEM CELLS DURING CHEMOTHERAPY AND TRANSPLANTATION
|
5K08CA197369-02
|
$121,394
|
WONG, TERRENCE
|
WASHINGTON UNIVERSITY
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
5P30CA013148-45
|
$5,113,872
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-45S1
|
$25,000
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-45S2
|
$125,000
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-45S3
|
$200,000
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Cytotoxicity of MLN4924 in Acute Myeloid Leukemia
|
5F30CA183507-04
|
$23,878
|
KNORR, KATHERINE
|
MAYO CLINIC ROCHESTER
|
|
Development of novel therapies for megakaryocytic malignancies
|
5R50CA211534-02
|
$130,753
|
WEN, QIANG
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Expanding multiplexed kinase biosensor analysis to SWATH-MS (1 of 2)
|
3R33CA183671-03S1
|
$76,541
|
PARKER, LAURIE
|
UNIVERSITY OF MINNESOTA
|
|
Genetic Analysis of Myeloproliferative Disease
|
3R01CA076167-14S1
|
$24,361
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-14
|
$307,800
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Genomic profiling and development of murine models of transformation of MPNs
|
5K08CA188529-04
|
$178,200
|
RAMPAL, RAAJIT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Genomics of Acute Myelogenous Leukemia
|
5P01CA101937-14
|
$2,917,422
|
LEY, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
|
5R01CA163926-05
|
$347,563
|
GREEN, MICHAEL
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Immunobiology for Marrow Allografts for Leukemia
|
5P01CA023766-38
|
$2,928,248
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
5UH2CA213385-02
|
$49,295
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Improving targeted therapies through functional genomic approaches
|
5F31CA189437-03
|
$21,152
|
WANG, TIM
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies
|
1R01CA216352-01
|
$338,672
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Integrated Training in Cancer Model Systems
|
3T32CA009156-41A1S1
|
$24,651
|
PAGANO, JOSEPH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Integrated Training in Cancer Model Systems
|
5T32CA009156-42
|
$789,141
|
PAGANO, JOSEPH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Leveraging epigenetic and epitranscriptomic aberrations in cancer to identify molecular targets for designing therapy
|
1F99CA223044-01
|
$45,544
|
SUNDARAVEL, SRIRAM
|
UNIVERSITY OF CHICAGO
|
|
Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
|
5R01CA173085-05
|
$328,888
|
BRAUN, BENJAMIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|